Richard Pazdur

FDA stop sign
Pharma

FDA leaders push for more US enrollment in cancer trials

The FDA wants to "see robust increased enrollment" of U.S. patients in oncology trials, Richard Pazdur, M.D., said during an adcomm meeting.
Angus Liu May 20, 2025 12:52pm
FDA conference hall

FDA to host first oncology adcomm meeting under Makary

May 8, 2025 11:35am
FDA

FDA looks to clarify follow-up testing mandate for speedy nods

Jan 6, 2025 3:36pm
FDA Building

2023 forecast: FDA revamps cancer drug approvals

Dec 21, 2022 5:00am
Influential regulators and advocates

Most influential people in biopharma—the regulators and advocates

May 23, 2022 3:00am
Asia map globe

FDA oncology chief, Senate bill, Insilico—Fierce Pharma Asia

Apr 1, 2022 9:35am